Drug recall · September 2, 2020
Heparin Sodium 5 recall
Why: Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Heparin Sodium 5,000 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (10 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0650-44, Bar Code 70004065044.
- Lots / codes
Lot #: 1220019289, Exp 08/21/2020.
- Quantity
- 366 Containers
- Company
- SCA Pharmaceuticals, Windsor, CT
- Distribution
- Nationwide within the U.S.
- Initiated
- July 29, 2020 · Voluntary: Firm initiated
- Classified
- August 27, 2020
- Reported
- September 2, 2020
- Ended
- May 21, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.